2025 年全球基因传递技术市场报告

预计未来几年基因转移技术的市场规模将快速成长。到 2029 年，这一数字将成长至 74.4 亿美元，复合年增长率为 14.7%。预测期内的成长可归因于精准医疗的发展、法规结构的加强、基因治疗的广泛应用以及非病毒递送系统的扩展。预测期内的主要趋势包括罕见疾病应用、增加临床试验、标靶药物传递、细胞疗法的扩展以及基因编辑工具的开发。

细胞和基因治疗的日益普及预计将推动基因转移技术市场未来的成长。细胞和基因疗法是治疗方法。这些治疗方法的兴起很大程度上是由基因编辑技术的进步所推动的，基因编辑技术在细胞和基因治疗方法的开发和商业化中发挥关键作用。例如，根据英国工业组织英国製药核准协会的数据，截至 2024 年 8 月，英国药品监管机构平均每年核准两种先进治疗药物 (ATMP)。然而，到 2030 年，这一数字预计将增加到每年 10 至 15 例。此外，到 2028 年，英国接受此类治疗的患者数量可能会从 2021 年的 2,500 人增加到每年 10,000 人。因此，细胞和基因治疗的兴起是推动基因转殖技术市场的关键因素。

个人化医疗日益增长的需求预计将在未来几年推动基因转移技术市场的成长。精准医疗是指一种客製化的医疗保健方法，考虑到患者的遗传、环境和生活方式等个别特征，以提高治疗效果和结果。多种因素导致个人化医疗的需求不断增加，包括基因组学的进步、患者权利的增强和治疗效果的改善。基因传递技术可以精确地瞄准特定的细胞和组织，确保仅在需要的地方进行治疗。例如，2024年2月，美国非营利组织个人化医疗联盟报告称，FDA将在2023年核准16种针对罕见疾病患者的新型个人化治疗方法，而2022年仅有6种。因此，个人化医疗需求的不断增长是基因转移技术市场的关键驱动力。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球基因转移技术市场的 PESTEL 分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
• 最终用途产业分析
• 全球基因传递技术市场：成长率分析
• 全球基因传递技术市场表现：规模与成长，2019 年至 2024 年
• 全球基因传递技术市场预测：规模与成长，2024-2029 年，2034 年
• 全球基因传递技术总目标市场 (TAM)

第六章 市场细分

• 全球基因传递技术市场（按模式、表现和预测），2019-2024 年、2024-2029 年、2034 年
• 生物
• 化学
• 身体的
• 全球基因传递技术市场（依方法、效能与预测），2019-2024 年、2024-2029 年、2034 年
• 体外
• 体内
• 试管内
• 全球基因传递技术市场的应用、效能与预测，2019-2024、2024-2029、2034
• 基因治疗
• 细胞疗法
• 疫苗
• 研究
• 全球基因传递技术市场：按类型、表现和预测进行生理细分，2019-2024 年、2024-2029 年、2034 年
• 病毒载体
• 细菌载体
• 脂质奈米颗粒
• 全球基因传递技术市场：按类型、性能和预测的化学细分，2019-2024 年、2024-2029 年、2034 年
• 阳离子脂质
• 聚合物
• 化学转染剂
• 全球基因传递技术市场：按类型、表现和预测进行实体细分，2019-2024 年、2024-2029 年、2034 年
• 电穿孔
• 显微注射
• 吉恩·甘
• Sonoporation

第七章 区域和国家分析

• 全球基因传递技术市场各地区、表现及预测，2019-2024、2024-2029、2034
• 全球基因传递技术市场（按国家/地区划分）、表现和预测，2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

• 基因传递技术市场：竞争格局
• 基因转殖技术市场：公司简介
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis
  • Horizon Discovery Group Co Overview, Products and Services, Strategy and Financial Analysis
  • OriGene Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Oxford Biomedica Solutions LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• SignaGen Laboratories LLC
• Vectalys SAS
• Takara Bio Inc.
• Bio-Rad Laboratories Inc.
• System Biosciences LLC
• Promega Corporation
• Hoffmann-La Roche AG
• Catalent Inc.
• Avantor
• Pfizer Inc.
• Becton Dickinson and Company
• Novartis AG
• Intellia Therapeutics Inc.
• Editas Medicine Inc.
• CRISPR Therapeutics AG

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年基因转殖技术市场：提供新机会的国家
• 基因传递技术市场 2029：提供新机会市场
• 基因传递技术市场 2029：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第 36 章 附录

Gene delivery technologies encompass methods utilized to introduce foreign genetic material, such as DNA or RNA, into cells, aiming to transfer the genetic material into the target cells. These technologies are commonly employed in the treatment of diseases or disorders resulting from altered genes, such as mutations or inherited genetic anomalies.

The primary types of gene delivery technologies modes include biological, chemical, and physical approaches. Biological methods involve the use of living organisms or their derivatives in the development and delivery of gene therapy products. Various techniques, such as ex vivo, in vivo, and in vitro applications, are employed in gene therapy, cell therapy, vaccines, and research.

The gene delivery technologies market research report is one of a series of new reports from The Business Research Company that provides gene delivery technologies market statistics, including gene delivery technologies industry global market size, regional shares, competitors with a gene delivery technologies market share, detailed gene delivery technologies market segments, market trends and opportunities, and any further data you may need to thrive in the gene delivery technologies industry. This gene delivery technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene delivery technologies market size has grown rapidly in recent years. It will grow from$3.79 billion in 2024 to $4.3 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to enhanced understanding of genetic diseases, advancements in cell therapy, evolution of nanotechnology, growth of gene therapy trials, research funding increase

The gene delivery technologies market size is expected to see rapid growth in the next few years. It will grow to $7.44 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to precision medicine development, regulatory framework enhancements, proliferation of gene therapy, expansion of non-viral delivery systems. Major trends in the forecast period include application in rare diseases, rise in clinical trials, targeted drug delivery, expansion of cell therapy, development of gene editing tools.

The growing prevalence of cell and gene therapies is projected to drive the growth of the gene delivery technologies market in the future. Cell and gene therapies are medical treatments designed to cure or alleviate diseases by modifying the genetic and cellular composition of a patient's body. The rise in these therapies is largely fueled by advancements in gene editing technologies, which play a crucial role in the development and commercialization of cell and gene therapies. For example, in August 2024, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported that the UK medicines regulator has historically approved an average of two advanced therapy medicinal products (ATMPs) annually. However, this number is expected to increase to 10-15 approvals per year by 2030. Additionally, the number of patients receiving these therapies in the UK could grow from 2,500 in 2021 to as many as 10,000 annually by 2028. Therefore, the rise in cell and gene therapies is a key factor driving the gene delivery technologies market.

The rising demand for personalized medicine is expected to drive the growth of the gene delivery technologies market in the future. Personalized medicine refers to a tailored healthcare approach that considers individual patient characteristics, such as genetics, environment, and lifestyle, to improve treatment effectiveness and outcomes. Several factors are contributing to the increased demand for personalized medicine, including advancements in genomics, greater patient empowerment, and enhanced treatment efficacy. Gene delivery technologies allow for the precise targeting of specific cells or tissues, ensuring that therapies are administered only where needed, which helps to minimize side effects and maximize therapeutic effectiveness. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to just six in 2022. Thus, the growing demand for personalized medicine is a significant driver of the gene delivery technologies market.

Technological advancement has become a prominent trend in the gene delivery technologies market. Major players in the market are directing their efforts toward the development of advanced products to fortify their market positions. For instance, in February 2023, Aera Therapeutics, a US-based biotechnology company, introduced Aera's Platform delivery technology, aiming to unlock the potential of genetic medicines. Aera's PNP technology facilitates precise targeting of RNA molecules implicated in disease processes, enabling the targeted editing of genes in a patient's cells and offering potential for personalized gene therapies.

Leading companies in gene delivery technologies are concentrating on the development of advanced products, such as the ProteoAnalyzer, to achieve a competitive advantage in the market. The ProteoAnalyzer is a sophisticated automated system created by Agilent Technologies specifically for protein analysis, utilizing parallel capillary electrophoresis (CE) technology. For example, in July 2024, Agilent Technologies Inc., a life sciences company based in the US, launched the ProteoAnalyzer system. This innovative platform is designed for automated parallel capillary electrophoresis, allowing for rapid and high-resolution protein analysis with minimal sample consumption. This feature is especially advantageous for researchers dealing with complex protein mixtures in pharmaceuticals, biopharma, and bioengineered food ingredients, enabling quicker discoveries and advancements in translational research. The system facilitates detailed analysis of protein mixtures, which is essential for the development of therapeutic proteins.

In January 2024, Kyowa Kirin Co. Ltd., a pharmaceutical company based in Japan, acquired Orchard Therapeutics plc for an undisclosed amount. This acquisition is intended to enhance Kyowa Kirin's gene therapy portfolio by utilizing Orchard Therapeutics' expertise in hematopoietic stem cell (HSC) gene therapies to tackle rare genetic diseases and broaden patient access to transformative treatments. Orchard Therapeutics plc is a biopharmaceutical company located in the UK that specializes in gene therapy.

Major companies operating in the gene delivery technologies market include Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Hoffmann-La Roche AG, Catalent Inc., Avantor, Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Regenexxbio Inc., Beam Therapeutics Inc., Verve Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG

North America was the largest region in the gene delivery technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gene delivery technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gene delivery technologies market consists of revenues earned by entities by providing services such as viral vector production, gene editing, gene therapy, and cell therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Gene delivery technologies also include sales of viral and non-viral vectors, transfection reagents, gene editing tools that are used in providing gene delivery. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Delivery Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene delivery technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene delivery technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene delivery technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Mode: Biological; Chemical; Physical
• 2) By Method: Ex Vivo; In Vivo; In Vitro
• 3) By Application: Gene Therapy; Cell Therapy; Vaccines; Research
• Subsegments:
• 1) By Biological: Viral Vectors; Bacterial Vectors; Lipid Nanoparticles
• 2) By Chemical: Cationic Lipids; Polymers; Chemical Transfection Agents
• 3) By Physical: Electroporation; Microinjection; Gene Gun; Sonoporation
• Companies Mentioned: Thermo Fisher Scientific Inc.; QIAGEN NV; Horizon Discovery Group Co; OriGene Technologies Inc.; Oxford Biomedica Solutions LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Delivery Technologies Market Characteristics

3. Gene Delivery Technologies Market Trends And Strategies

4. Gene Delivery Technologies Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Gene Delivery Technologies Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gene Delivery Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gene Delivery Technologies Market Growth Rate Analysis
• 5.4. Global Gene Delivery Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gene Delivery Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gene Delivery Technologies Total Addressable Market (TAM)

6. Gene Delivery Technologies Market Segmentation

• 6.1. Global Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biological
• Chemical
• Physical
• 6.2. Global Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ex Vivo
• In Vivo
• In Vitro
• 6.3. Global Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Cell Therapy
• Vaccines
• Research
• 6.4. Global Gene Delivery Technologies Market, Sub-Segmentation Of Biological, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Vectors
• Bacterial Vectors
• Lipid Nanoparticles
• 6.5. Global Gene Delivery Technologies Market, Sub-Segmentation Of Chemical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cationic Lipids
• Polymers
• Chemical Transfection Agents
• 6.6. Global Gene Delivery Technologies Market, Sub-Segmentation Of Physical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electroporation
• Microinjection
• Gene Gun
• Sonoporation

7. Gene Delivery Technologies Market Regional And Country Analysis

• 7.1. Global Gene Delivery Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gene Delivery Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Delivery Technologies Market

• 8.1. Asia-Pacific Gene Delivery Technologies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Delivery Technologies Market

• 9.1. China Gene Delivery Technologies Market Overview
• 9.2. China Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Delivery Technologies Market

• 10.1. India Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Delivery Technologies Market

• 11.1. Japan Gene Delivery Technologies Market Overview
• 11.2. Japan Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Delivery Technologies Market

• 12.1. Australia Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Delivery Technologies Market

• 13.1. Indonesia Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Delivery Technologies Market

• 14.1. South Korea Gene Delivery Technologies Market Overview
• 14.2. South Korea Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Delivery Technologies Market

• 15.1. Western Europe Gene Delivery Technologies Market Overview
• 15.2. Western Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Delivery Technologies Market

• 16.1. UK Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Delivery Technologies Market

• 17.1. Germany Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Delivery Technologies Market

• 18.1. France Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Delivery Technologies Market

• 19.1. Italy Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Delivery Technologies Market

• 20.1. Spain Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Delivery Technologies Market

• 21.1. Eastern Europe Gene Delivery Technologies Market Overview
• 21.2. Eastern Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Delivery Technologies Market

• 22.1. Russia Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Delivery Technologies Market

• 23.1. North America Gene Delivery Technologies Market Overview
• 23.2. North America Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Delivery Technologies Market

• 24.1. USA Gene Delivery Technologies Market Overview
• 24.2. USA Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Delivery Technologies Market

• 25.1. Canada Gene Delivery Technologies Market Overview
• 25.2. Canada Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Delivery Technologies Market

• 26.1. South America Gene Delivery Technologies Market Overview
• 26.2. South America Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Delivery Technologies Market

• 27.1. Brazil Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Delivery Technologies Market

• 28.1. Middle East Gene Delivery Technologies Market Overview
• 28.2. Middle East Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Delivery Technologies Market

• 29.1. Africa Gene Delivery Technologies Market Overview
• 29.2. Africa Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Delivery Technologies Market Competitive Landscape And Company Profiles

• 30.1. Gene Delivery Technologies Market Competitive Landscape
• 30.2. Gene Delivery Technologies Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Horizon Discovery Group Co Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. OriGene Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Oxford Biomedica Solutions LLC Overview, Products and Services, Strategy and Financial Analysis

31. Gene Delivery Technologies Market Other Major And Innovative Companies

• 31.1. SignaGen Laboratories LLC
• 31.2. Vectalys SAS
• 31.3. Takara Bio Inc.
• 31.4. Bio-Rad Laboratories Inc.
• 31.5. System Biosciences LLC
• 31.6. Promega Corporation
• 31.7. Hoffmann-La Roche AG
• 31.8. Catalent Inc.
• 31.9. Avantor
• 31.10. Pfizer Inc.
• 31.11. Becton Dickinson and Company
• 31.12. Novartis AG
• 31.13. Intellia Therapeutics Inc.
• 31.14. Editas Medicine Inc.
• 31.15. CRISPR Therapeutics AG

32. Global Gene Delivery Technologies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Delivery Technologies Market

34. Recent Developments In The Gene Delivery Technologies Market

35. Gene Delivery Technologies Market High Potential Countries, Segments and Strategies

• 35.1 Gene Delivery Technologies Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gene Delivery Technologies Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gene Delivery Technologies Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer